home home contact us contact us how to reach us how to reach us sitemap sitemap
search
 
 
DISEASE   TARGETS
Alzheimer's Disease
Huntington's Disease
Neuro-Oncology
Orphan Diseases
 
 
Huntington’s Disease (HD) is a rare inherited neurodegenerative disorder sometimes also referred to as Huntington's chorea. The greek word chorea means "dance" and refers to the characteristic movement disorder that is part of the illness.

The genetic origin of HD was already recognized in the first description of the Disease in 1872 and the Disease gene (huntingtin, htt) identified in 1993. HD is caused by an insertion of CAG repeats in the huntingtin gene but it is not completely clear how mutated Htt mediates toxicity. A Disease-modifying therapy is not available yet.

HD Research


An exploratory research program in collaboration with the University of Cambridge (UK) elucidates Htt-mediated pathological mechanism(s) in a systematic manner.

The aim of this program is to further the understanding of Htt-mediated toxicity which should lead to novel targets for therapeutic intervention. The scope of another research program is the identification of inhibitors of Htt-mediated toxicity for pharmacological therapy.
 
 
 
|  Privacy Policy  |   © 2008 - Siena Biotech ®